Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-14-020603

Director acquired 36,502 shares (grant or award)

  • Director acquired 1,543,989 shares (conversion)
  • Director returned 1,543,989 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Bridger Gary · Director

Table I: Non-derivative

8 lines

Table II: Derivative

17 lines
Date Transaction Shares Price Value Underlying Owned after D/I
2014-03-12 Grant or award : show line 9 in the form Common Exchangeable Shares +36,502 $11.00 $401,522 36,502 40,147 I
2014-03-12 Conversion : show line 10 in the form Common Exchangeable Shares −40,147 40,147 0 I
2014-03-12 Conversion : show line 11 in the form Series A-1 Exchangeable Shares −284,090 284,090 0 I
2014-03-12 Conversion : show line 12 in the form Series A-1 Preferred Stock +284,090 284,090 0 I
2014-03-12 Conversion : show line 13 in the form Series A-1 Preferred Stock −284,090 284,090 0 I
2014-03-12 Conversion : show line 14 in the form Series A-2 Exchangeable Shares −189,393 189,393 0 I
2014-03-12 Conversion : show line 15 in the form Series A-2 Preferred Stock +189,393 189,393 0 I
2014-03-12 Conversion : show line 16 in the form Series A-2 Preferred Stock −189,393 189,393 0 I
Loading xslF345X03/doc4.xml…